[PHARMA] QoQ TTM Result on 31-Dec-2014 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
23-Feb-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Dec-2014 [#4]
Profit Trend
QoQ- 20.37%
YoY- 70.01%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Revenue 2,136,265 2,113,938 2,126,165 2,122,933 2,063,690 2,002,411 1,914,972 7.55%
PBT 126,859 126,467 126,033 125,580 120,733 109,249 94,232 21.89%
Tax -21,695 -26,277 -26,528 -31,355 -41,862 -41,209 -35,978 -28.60%
NP 105,164 100,190 99,505 94,225 78,871 68,040 58,254 48.20%
-
NP to SH 104,679 99,663 99,421 93,844 77,960 66,756 56,646 50.53%
-
Tax Rate 17.10% 20.78% 21.05% 24.97% 34.67% 37.72% 38.18% -
Total Cost 2,031,101 2,013,748 2,026,660 2,028,708 1,984,819 1,934,371 1,856,718 6.16%
-
Net Worth 534,373 528,477 528,173 525,351 507,124 502,293 515,022 2.48%
Dividend
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Div 90,625 88,011 80,234 72,463 57,457 44,519 42,973 64.37%
Div Payout % 86.57% 88.31% 80.70% 77.22% 73.70% 66.69% 75.86% -
Equity
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Net Worth 534,373 528,477 528,173 525,351 507,124 502,293 515,022 2.48%
NOSH 259,027 259,057 258,908 258,794 258,737 258,914 258,805 0.05%
Ratio Analysis
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
NP Margin 4.92% 4.74% 4.68% 4.44% 3.82% 3.40% 3.04% -
ROE 19.59% 18.86% 18.82% 17.86% 15.37% 13.29% 11.00% -
Per Share
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
RPS 824.73 816.01 821.20 820.32 797.60 773.39 739.93 7.49%
EPS 40.41 38.47 38.40 36.26 30.13 25.78 21.89 50.42%
DPS 35.00 34.00 31.00 28.00 22.20 17.20 16.61 64.28%
NAPS 2.063 2.04 2.04 2.03 1.96 1.94 1.99 2.42%
Adjusted Per Share Value based on latest NOSH - 258,794
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
RPS 148.22 146.67 147.52 147.30 143.19 138.94 132.87 7.55%
EPS 7.26 6.92 6.90 6.51 5.41 4.63 3.93 50.49%
DPS 6.29 6.11 5.57 5.03 3.99 3.09 2.98 64.47%
NAPS 0.3708 0.3667 0.3665 0.3645 0.3519 0.3485 0.3573 2.50%
Price Multiplier on Financial Quarter End Date
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Date 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 -
Price 6.50 7.13 6.00 4.58 4.63 4.61 4.46 -
P/RPS 0.79 0.87 0.73 0.56 0.58 0.60 0.60 20.10%
P/EPS 16.08 18.53 15.62 12.63 15.37 17.88 20.38 -14.60%
EY 6.22 5.40 6.40 7.92 6.51 5.59 4.91 17.06%
DY 5.38 4.77 5.17 6.11 4.79 3.73 3.72 27.85%
P/NAPS 3.15 3.50 2.94 2.26 2.36 2.38 2.24 25.49%
Price Multiplier on Announcement Date
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Date 26/11/15 17/08/15 18/05/15 23/02/15 21/11/14 21/08/14 14/05/14 -
Price 6.50 5.65 6.91 5.28 4.45 4.62 4.70 -
P/RPS 0.79 0.69 0.84 0.64 0.56 0.60 0.64 15.05%
P/EPS 16.08 14.69 17.99 14.56 14.77 17.92 21.47 -17.51%
EY 6.22 6.81 5.56 6.87 6.77 5.58 4.66 21.20%
DY 5.38 6.02 4.49 5.30 4.99 3.72 3.53 32.40%
P/NAPS 3.15 2.77 3.39 2.60 2.27 2.38 2.36 21.20%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment